Update on ventricular assist devices

Current Opinion in Anaesthesiology

Volumn 23, Issue 1, 2010, Pages 57-66

  Mitter, Nanhi ^a   Sheinberg, Rosanne ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Bridge to transplantation; Destination therapy; Heart failure; Mechanical support; Ventricular assist devices

Indexed keywords

ANTICOAGULATION; ARTIFICIAL HEART; ARTIFICIAL VENTILATION; BODY SURFACE; ELECTROCARDIOGRAM; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART OUTPUT; HEART TRANSPLANTATION; HOSPITAL DISCHARGE; HOSPITALIZATION; INTENSIVE CARE UNIT; PATIENT MOBILITY; PRIORITY JOURNAL; REVIEW;

HEART FAILURE; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HUMANS;

EID: 75149145062     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283346c83     Document Type: Review

References (30)

1. Joyce LD, Noon GP, Joyce DL, et al. Mechanical circulatory support: a historical review. ASAIO J 2004; 50:x-xii.
2. Debakey ME. Development of mechanical heart devices. Ann Thorac Surg 2005; 79:S2228-S2231.
3. Christiansen S, Klocke A, Autschbach R. Past, present, and future of longterm mechanical cardiac support in adults. J Card Surg 2008; 23:664-676.
4. Shoham S, Miller LW. Cardiac assist device infections. Curr Infect Dis Repo 2009; 11:268-273.
5. Schulman AR, Maretens TP, Christos PJ, et al. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular devices. J Thorac Cardiovasc Surg 2007; 133:841-842.
6. Kirsch M, Vermes E, Damy T, et al. Single-centre experience with the Thoratec paracorporeal ventricular assist device for patients with primary cardiac failure. Arch Cardiovasc Dis 2009; 102:509-518.
7. Sayer G, Yoshifumi N, Jorde UP. Ventricular assist device. Cardiovasc Ther 2009; 27:140-150.
8. Magner J, Royston D. Heart failure. Br J Anaesth 2004; 93:74-85.
9. Petrucci RJ, Wright S, Naka Y, et al. Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist device. J Heart Lung Transplant 2009; 28:542-549.
10. John R. Current axial-flow devices: The HeartMate II and Jarvik 2000 left ventricular assist devices. Semin Thorac Cardiovasc Surg 2008; 20:264-272.
11. Ribera E, Lanfranconi M, et al. Bridge to transplantation with the MicroMed DeBakey ventricular assist device axial pump: a single centre report. J Cardiovasc Med 2006; 7:114-118.
12. Slaughter MS, Sobieski MA, Gallagher C, et al. Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device. Tex Heart Inst J 2008; 35:245-249.
13. Leprince P, Bonnet N, Varnous S, et al. Patients with a body surface area less than 1.7m2 have a good outcome with the cardiowest total artificial heart. J Heart Lung Transplant 2005; 24:1501-1505.
14. Frazier OH, Dowling RD, Gray LA, et al. The total artificial heart: where we stand. Cardiology 2004; 101:117-121.
15. Lahpor JR. State of the art: implantable ventricular assist devices. Curr Opin Organ Transplant 2009 [Epub ahead of print].
16. Clinical policy bulletin: ventricular assist devices (number 0654). Aetna. http://www.aetna.com/cpb/medical/data/600-699/0654.html. [Last accessed 19 November 2008]
17. McBride LR, Naunheim KS, Fiore AC, et al. Clinical experience with 111 Thoratec ventricular assist devices. Ann Thorac Surg 1999; 67:1233-1238.
18. Dekkers RJ, FitzGerald DJ, Couper GS. Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure. Perfusion 2001; 16:13-18.
19. Luo X, Hu S, Sun H, et al. Clinical application of BVS 5000 left ventricular assist device in heart failure patients. Chin Med J 2008; 121:877-880.
20. Mancini D, Burkhoff D. Mechanical device-based methods of managing and treating heart failure. Circulation 2005; 112:438-448.
21. Lazar RM, Shapiro PA, Jaski BE, et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation 2004; 109:2423-2427.
22. Rose EA, Gelijns AC, Moskowita AJ, et al. Long-term use of left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345:1435-1443.
23. Loforte A, Montalto A, Ranocchi F, et al. Heartmate II axial-flow left ventricular assist system: management, clinical review and personal experience. J Cardiovasc Med 2009; 10:765-771.
24. John R, Kamdar F, Liao K, et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-totransplant therapy. Ann Thorac Surg 2008; 86:1227-1235.
25. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357:885-896.
26. Siegenthaler MP, Martin J, Pernice K, et al. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiovasc Surg 2003; 23:748-755.
27. Siegenthaler MP, Frazier OH, Beyersdorf F, et al. Mechanical reliability of the Jarvik 2000 heart. Ann Thorac Surg 2006; 81:1752-1759.
28. Garatti A, Giuseppe B, Colombo T, et al. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices. Eur J Cardiothorac Surg 2008; 34:275-280.
29. Slaughter MS, Tsui SS, El-Banayosy A, et al. Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device. J Thorac Cardiovasc Surg 2007; 133:1573-1580.
30. Dowling RD, Gray LA, Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004; 127:131-141.